Cite
HARVARD Citation
Kopić, A. et al. (n.d.). Preclinical assessment of a new recombinant ADAMTS‐13 drug product (BAX930) for the treatment of thrombotic thrombocytopenic purpura. Journal of thrombosis and haemostasis. pp. 1410-1419. [Online].